Commentary
In Western populations, major aetiological factors for the development of intraoral cancer are smoking and alcohol misuse. Several other factors remain speculative and viral infections are included in this group. In the last 20 years, evidence has accumulated regarding the possible association of oncogenic high-risk types of HPV with OSCC. HPV is already implicated in cervical cancer, anorectal cancers and among head and neck cancers for tonsillar carcinoma. This meta-analysis assessing the risk of HPV status in OSCC and oral premalignant lesions is timely.
The authors carried out a MEDLINE search and hand-searched information using the available review articles. Some grey literature from case reports was included in addition to reported clinical series. The criteria used for tissue sampling and anatomical locations of cancers are clear.
The authors conclude that HPV infection with high-risk genotypes is a significant risk factor for OSCC. In the 94 reports accessed, the incidence of HPV ranged from 0 to 100%. This demonstrates the enormous variation expected in finding HPV in OSCC, largely due to different laboratory techniques employed. In two reports from their own laboratory within a time-period of 1 year the reported detection rate of HPV in OSCC rose from 0% (when in situ hybridisation was employed) to 67% (when PCR was utilised). The meta-analysis included assay-sensitivity estimates but these analyses produced results similar to the unadjusted analyses. Further factors to consider in risk assessments are age and population differences. Role of HPV in oral carcinogenesis appears to be minor compared with smoking and alcohol but special population groups may be at risk. For example, Scully 2 raises the potential for sexual transmission of HPV as an aetiological factor for OSCC in young male adults.
How infection of oral keratinocytes by HPV contributes to malignant transformation has been reviewed. 3 Oncogenic proteins encoded by E6 and E7 genes from high-risk HPV genotypes (mainly HPV-16 and -18) are able to disrupt cell cycle regulatory proteins such and p53 and pRB by stimulating their degradation. Few studies of HPV E6/E7 gene expression in OSCC 4 exist, but the theoretical model supports the biological role of HPV. The present article is a valuable contribution, identifying the need for more rigorous research to quantify accurately HPV infection in OSCC. The reviewer is aware of two recent studies, a multicentre study coordinated by the IARC (International Agency for Research on Cancer) and another at John Hopkins University (Baltimore, MD, USA) that may further strengthen our knowledge on the role of HPV in OSCC. Translating these important laboratory findings of HPV infection in neoplasia to therapeutic interventions is already in progress. 
